Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/10/2026 ,inter alia, to consider and approve matters as attached

ASSTON PHARMACEUTICALS LIMITED (FORMERLY KNOWN AS ASSTON PHARMACEUTICALS PRIVATE LIMITED) To, Date: 06th October, 2026 BSE Limited Listing / Compliance Department, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai, 400001 BSE Code: 544445 ISIN: INE0SJX01015 Sub: Board Meeting Intimation under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir/ Madam, Pursuant to Regulation 29(1) of the SEBI Listing Regulations, we wish to inform you that a Meeting of the Board of Directors (the "Board") of the Company will be held on Tuesday, 13th October, 2026, to consider and approve the following matters: 1. To consider and approve the shifting of the registered office address of the Company; 2. To consider and approve the acquisition of immovable property through Bank/Financial Institution Auction; 3. Other incidental matters Kindly take the same on record. Thanking you, For and on behalf of the Board of Directors Rishi Upadhaya Company Secretary & Compliance Officer A74324 CIN: U24304MH2019PLC324187 Reg. Office- 4th Floor Office No A-431 Balaji Bhavan, Plot No 42a Sector-11 CBD Belapur, Navi Mumbai, Thane, Maharashtra, 400614, India Phone No.: 022-49731419 / 49731411, Email id: aston.tech14@gmail.com/compliance@asstonpharmaceuticals.com Web: www.asstonpharmaceuticals.com